The Diagnostic Significance of G/GM Assay for Invasive Fungal Infections in Patients with Hematological Malignancies

TONG Tong,SHEN Jilu,XU Yuanhong,WANG Zhongxin

DOI: https://doi.org/10.13381/j.cnki.cjm.201610009

2016-01-01

Abstract:Objective To explore the clinical significance of serum(1,3)-β-D-glucan and serum galactomannan for diagnosis of invasive fungal disease(IFD)in patients with hematological malignancies.Methods 193 patients with high risk invasive fungal infections(IFIs)from the department of hemopathology of our hospital were included.The sensitivity,specificity,positive predictive value(PPV)and negative predictive value(NPV)of(1,3)-β-D-glucan test and galactomannan test and the combination of both in the diagnosis of IFD were calculated.The change of galactomannan results during treatment was also analyzed in the patients who received antifungal therapy.Results The sensitivity,specificity,PPV,and NPV of(1,3)-β-D-glucan among IFD patients with hematological malignancies were 71.7%,89.3%,71.7% and 89.3% respectively,those of galactomannan test were 54.7%,94.3%,78.4% and 84.6% respectively,those of serial analysis were39.6%,99.3%,95.5% and 81.3% respectively,and those of parallel analysis were 86.6%,84.3%,67.7% and 94.4% respectively.17 galactomannan positive patients received antifungal therapy;14responded to the treatment while 3did not.The galactomannan value in the effective group decreased from the second week and reached to normal level in the third weeks,while that in the ineffective group continued to increase.There was statistical difference between the effective group and ineffective group(P<0.05).Conclusion Serum(1,3)-β-D-glucan and serum galactomannan assay as the diagnostic indexes of IFD can provide a strong evidence for early diagnosis of IFI in patients with hematological malignancies,and combined diagnosis can provide more valuable clinical value.Dynamic monitoring of galactomannan is useful for assessing the efficacy of clinical antifungal therapy.